Share

The Long Haul: Treating Men with Obesity with Testosterone

A study presented at ENDO 2019 shows that long-term testosterone therapy in men with obesity and hypogonadism can actually contribute to prolonged weight loss without an added risk for mortality or major cardiovascular incidents. As obesity rates around the world continue to climb – the number has tripled since 1975 – physicians and health organizations...
Share

Q&A: Derek LeRoith, MD, PhD, Discusses Society Guideline on Treating Older Patients with Diabetes

LeRoith.Derek Endocrine News talks with Derek LeRoith MD, PhD, chair of the guideline writing committee that created the latest Endocrine Society Clinical Practice Guideline on Treatment of Diabetes in Older Adults. Simplifying medication regimens and tailoring glycemic targets in older adults with diabetes improves adherence and avoids treatment-related complications, according to the latest clinical practice guideline released by the...
Share

All Inclusive: Q&A with the NIH’s Kelly Gebo, MD, MPH

GEBO kelly 3 Endocrine News talks with Kelly Gebo, MD, MPH, the chief medical and scientific officer of the NIH’s All of Us program, who explains why “one size does not fit all” when it comes to healthcare delivery and how this ambitious research program could be useful for both endocrine clinicians and scientists alike.  A new research...
Share

FDA Approves New Treatment for Osteoporosis in Postmenopausal Women at High Risk of Fracture

The U.S. Food and Drug Administration has approved romosozumab-aqqg to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture). These are women with a history of osteoporotic fracture or multiple risk factors for fracture, or those who have failed or are intolerant to other osteoporosis therapies. The drug will be marketed...